ArticleNew microbes and new infections2026
Trends and burden of diarrhoeal diseases across India, 1990 - 2023: A systematic analysis from the global burden of disease study 2023.
Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite substantial progress, diarrhoeal diseases continue to pose a significant public health burden, with marked regional, age-specific, and pathogen-specific disparities. The persistence of high mortality in certain states, elevated vulnerability among young children and older adults, and the shifting dominance of diarrhoeal pathogens highlight gaps in prevention, sanitation, nutrition, and healthcare access. Objectives: To assess long-term trends in diarrhoeal disease burden in India from 1990 to 2023, including mortality, DALYs, YLLs, YLDs, associated risk factors and etiologies, and to examine age- and state-level variations. Methods: The analysis and findings presented in this article are based on data from the Global Burden of Disease (GBD) 2023 study. Trends were analysed using joinpoint regression to calculate annual percentage change (APC) and average annual percentage change (AAPC) by state and sex. Statistical significance was defined as a two-sided p-value of <0.05. Results: In 2023, an estimated 0.46 million deaths in India were attributable to diarrhoeal diseases across all age group, which showed a 68.3% reduction from 1.46 million in 1990. Age-standardised death and DALYs rates declined by 84.5% and 87.4%, respectively. Children under five showed the greatest improvement, with neonatal mortality falling by 94.1%, and the largest reduction (98.0%) among children aged 2-4 years. Conclusion: India has achieved a substantial decline in diarrhoeal mortality over the past three decades, particularly among children under 5 years. This progress may be attributed to initiatives like improved sanitation, safe drinking water, roll out of rotavirus vaccines and better healthcare access. Future efforts should prioritize strengthening WASH interventions, expanding vaccine coverage, and targeting high-burden populations, particularly children and older adults.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.